Skip to content

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06089161
Acronym
PRAISE
Enrollment
330
Registered
2023-10-18
Start date
2024-03-19
Completion date
2028-05-31
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Brief summary

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Interventions

OTHERStandard of Care

Participants in this group will receive standard of care treatment for sleep apnea.

BEHAVIORALPersonalized OSA Treatment

Participants in this group will receive standard of care treatment plus the personalized treatment that consists of videos approximately three minutes long, virtual, accessed through web based application, that the participant watches weekly. The purpose of the video is tailored educational content for sleep apnea.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Self-reported race/ethnicity as African American, African, Caribbean or black * Ages 60-85 years * accessible by phone * OSA diagnosis * consent, including permission to release medical data

Exclusion criteria

* progressive illnesses in which disability or death is expected within 1 year * impaired cognitive/ functional ability precluding participation * intention to move within the year * and a family member currently enrolled.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants adherence to OSA treatmentUp to 6 monthsThe proportion of participants who answer yes (meaning a participant acknowledges an average of more than 4 hours of continuous positive airway pressure use) or no (meaning a participant acknowledges an average of less than 4 hours of continuous positive airway pressure use).

Secondary

MeasureTime frameDescription
Change in the number of floors climbed measured by FitbitBaseline, 2 monthsNumber of floors climbed
Change in distance traveled measured in Miles by FitbitBaseline, 2 monthsdistance traveled measured by mile
Change in number of steps taken measured by FitbitBaseline, 2 monthsnumber of steps taken
Change in Cardiometabolic Biomarkers Measured picograms per milliliterBaseline and 6 monthsVitamin B12. Measured picograms per milliliter.
Change in Molecular BiomarkersBaseline and 6 monthsThe molecular biomarker are C₂N, Homocysteine, Neurofilament light, Glial fibrillary acidic protein, Tau, and Amyloid-Beta peptides and the inflammatory markers are Interleukin-6,Interleukin -10, and Tumor Necrosis Factor-alpha. All will be measured in picograms per milliliter.
Change in Vascular MarkersBaseline and 6 monthsRed Blood Cell Count, White Blood Cell Count, and Platelet Count will be measured. All will be measured in Cells/L.
Change in Cardiometabolic Biomarkers measured in mg/dlBaseline and 6 monthsTotal Cholesterol, HDL, LDL, Triglycerides, Bilirubin, Blood Urea Nitrogen (BUN), Calcium, Creatinine, and Glucose. Measured in milligrams/deciliter (mg/dl) assessed with blood analyses.
Change in Cardiometabolic Biomarkers as measured in grams per deciliterBaseline and 6 monthsHemoglobin, Albumin, and Total Protein. Measured in grams per deciliter assessed with blood analyses.
Change in Cardiometabolic Biomarkers measured in mmol/molBaseline and 6 monthsGlucose/HbA1C, Chloride, Potassium, Sodium, Homocysteine. Measured in mmol/mol assessed with blood analyses
Change in Cardiometabolic Biomarkers- platelet countBaseline and 6 monthsPlatelet Count. Measured per microliter of Blood.
Change in Cardiometabolic Biomarkers as measured per microliter of Blood.Baseline and 6 monthsBlood Pressure. Measured per microliter of Blood.
Change in Cardiometabolic Biomarkers as measured by Milli-international units per litre.Baseline and 6 monthsThyroid-stimulating hormone. Measured Milli-international units per litre.
Change in Cardiometabolic Biomarkers as measured milligrams per literBaseline and 6 monthsC-reactive protein Highly Sensitive. Measure milligrams per liter.
Change in Cardiometabolic Biomarkers Measured in microgramBaseline and 6 monthsFolate. Measured microgram.
Change in NIH Toolbox -Oral Reading Recognition TestBaseline, 6 monthsAn assessment of reading decoding skills and crystalized abilities. Participants are asked to read aloud letters and words, pronouncing the words as accurately as possible.
Change in number of calories burned measured by FitBitBaseline, 2 months, 6 monthsNumber of Calories burned
Change in NIH Toolbox- Flanker Inhibitory Control and AttentionBaseline, 6 monthsAn assessment of inhibitory control and attention. The participant is asked to focus on a particular stimulus while inhibiting attention to the stimuli flanking it. This outcome will be reported as a composite score.
Change in Executive Function measured by Dimensional Change Card Sort TestBaseline, 6 monthsExecutive function, An assessment of cognitive flexibility and attention. The participant is asked to match a series of picture pairs to a target picture.
Change in Episodic memory measured by Picture Sequence Memory TestBaseline, 6 monthsEpisodic memory, An assessment of episodic memory. Participants are shown a number of activities, and then asked to reproduce the sequence of pictures as it was presented.
Change in NIH Toolbox- Auditory Verbal Learning TestBaseline, 6 monthsParticipants are given three trials to recall as many words as possible from a list of fifteen unrelated words. After a 5-25 minute delay, participants are asked to freely recall as many of the 15 words as possible..
Change in Working Memory measured by List Sorting TaskBaseline, 6 monthsWorking memory, An assessment of working memory. The participant is asked to recall and sequence different stimuli that are presented visually and via audio.
Change in Processing Speed measured by Patten Comparison Processing Speed TestBaseline, 6 monthsProcessing speed, An assessment of processing speed. Participants are asked to quickly determine whether two stimuli are the same or not the same.
Change in Working Memory measured by Number Span SubsetBaseline, 6 monthsIn this test, the participant is asked to recall a series of numbers in reverse order. The correctly recalled series are scored as 1, and the test contains 14 sequences of numbers. The range of working memory score is from 0 to 14, with higher values representing better outcome.
Change in Health-related quality of lifeBaseline, 2 months, 6 monthsPatient-Reported Outcomes Measurement Information System Short Form v1.1 - Global Health (5. Excellent, 4. Very good, 3. Good, 2. Fair, 1. Poor) Higher score indicates better self-reported health-related quality of life
Change in Daytime functioningBaseline, 2 months, 6 monthsPatient-Reported Outcomes Measurement Information System Short form v1.0 Sleep-Related Impairment 8a (1. Not at all 2. A little bit 3. Somewhat 4. Quite a bit 5. Very much) A lower score indicates better daytime functioning
Changes in Sleep Quality measured by Patient-Reported Outcomes Measurement Information System Short Form v1.0 Sleep DisturbanceBaseline, 2 months, 6 monthsPatient-Reported Outcomes Measurement Information System Short Form v1.0 Sleep Disturbance 4a (1. Not at all 2. A little bit 3. Somewhat 4. Quite a bit 5. Very much)
Changes in number of minutes as measured by FitBit Sleep StagesBaseline, 2 months, 6 monthsSleep quality will be measured by the number of minutes by FitBit Sleep Stages.
Changes in Sleep quality measured by Sleep ScoreBaseline, 2 months, 6 monthsFitBit Sleep score: Excellent: 90 to 100 Good: 80 to 89 Fair: 60 to 79 Poor: less than 60 Min: 1 Max: 100 Excellent: 90-100 Good: 80-89 Fair: 60-79 Poor: Less than 60
Change in Cardiometabolic Biomarkers as measured in percentageBaseline and 6 monthsHematocrit. Measured as a percentage.
Change in Sleep Awakening measured by FitbitBaseline, 2 monthsNumber of awakenings
Change in NIH Toolbox Picture Vocabulary TestBaseline, 6 monthsAn assessment of receptive vocabulary administered in a computer-adaptive test (CAT) format. Participants must choose which of four pictures best represents a word presented via audio.

Countries

United States

Contacts

Primary ContactGirardin Jean-Louis, PhD
girardin.jean-louis@miami.edu3052430776

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026